RESUMEN
With the emergence of Low-Cost Sensor (LCS) devices, measuring real-time data on a large scale has become a feasible alternative approach to more costly devices. Over the years, sensor technologies have evolved which has provided the opportunity to have diversity in LCS selection for the same task. However, this diversity in sensor types adds complexity to appropriate sensor selection for monitoring tasks. In addition, LCS devices are often associated with low confidence in terms of sensing accuracy because of the complexities in sensing principles and the interpretation of monitored data. From the data analytics point of view, data quality is a major concern as low-quality data more often leads to low confidence in the monitoring systems. Therefore, any applications on building monitoring systems using LCS devices need to focus on two main techniques: sensor selection and calibration to improve data quality. In this paper, data-driven techniques were presented for sensor calibration techniques. To validate our methodology and techniques, an air quality monitoring case study from the Bradford district, UK, as part of two European Union (EU) funded projects was used. For this case study, the candidate sensors were selected based on the literature and market availability. The candidate sensors were narrowed down into the selected sensors after analysing their consistency. To address data quality issues, four different calibration methods were compared to derive the best-suited calibration method for the LCS devices in our use case system. In the calibration, meteorological parameters temperature and humidity were used in addition to the observed readings. Moreover, we uniquely considered Absolute Humidity (AH) and Relative Humidity (RH) as part of the calibration process. To validate the result of experimentation, the Coefficient of Determination (R2), Root Mean Square Error (RMSE), and Mean Absolute Error (MAE) were compared for both AH and RH. The experimental results showed that calibration with AH has better performance as compared with RH. The experimental results showed the selection and calibration techniques that can be used in designing similar LCS based monitoring systems.
Asunto(s)
Contaminantes Atmosféricos , Contaminación del Aire , Contaminantes Atmosféricos/análisis , Contaminación del Aire/análisis , Calibración , Monitoreo del Ambiente , Material Particulado/análisisRESUMEN
Current drug-delivery systems are designed primarily for parenteral applications and are either lipid or polymer drug conjugates. In our quest to inhibit herpes simplex virus infection via the compounds found in commonly used cosmetic products, we found that activated carbon particles inhibit infection and, in addition, substantially improve topical delivery and, hence, the efficacy of a common antiviral drug, acyclovir (ACV). Our in vitro studies demonstrate that highly porous carbon structures trapped virions, blocked infection and substantially improved efficacy when ACV was loaded onto them. Also, using murine models of corneal and genital herpes infections, we show that the topical use of drug-encapsulated carbon (DECON) reduced dosing frequency, shortened treatment duration, and exhibited higher therapeutic efficacy than currently approved topical or systemic antivirals alone. DECON is a nontoxic, cost-effective and nonimmunogenic alternative to current topical drug-delivery systems that is uniquely triggered for drug release by virus trapping.
Asunto(s)
Aciclovir/administración & dosificación , Aciclovir/uso terapéutico , Antivirales/uso terapéutico , Enfermedades de la Córnea/tratamiento farmacológico , Portadores de Fármacos/uso terapéutico , Herpes Genital/tratamiento farmacológico , Herpesvirus Humano 1/efectos de los fármacos , Animales , Antivirales/administración & dosificación , Células CHO , Carbono/química , Línea Celular Tumoral , Carbón Orgánico/química , Chlorocebus aethiops , Enfermedades de la Córnea/virología , Cricetulus , Modelos Animales de Enfermedad , Femenino , Células HeLa , Herpes Genital/virología , Humanos , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Células VeroRESUMEN
Herpes simplex virus type 1 (HSV-1) causes recurrent mucocutaneous lesions in the eye that may advance to corneal blindness. Nucleoside analogs exemplified by acyclovir (ACV) form the primary class of antiherpetic drugs, but this class suffers limitations due to the emergence of viral resistance and other side effects. While studying the molecular basis of ocular HSV-1 infection, we observed that BX795, a commonly used inhibitor of TANK-binding kinase 1 (TBK1), strongly suppressed infection by multiple strains of HSV-1 in transformed and primary human cells, cultured human and animal corneas, and a murine model of ocular infection. Our investigations revealed that the antiviral activity of BX795 relies on targeting Akt phosphorylation in infected cells, leading to the blockage of viral protein synthesis. This small-molecule inhibitor, which was also effective against an ACV-resistant HSV-1 strain, shows promise as an alternative to existing drugs and as an effective topical therapy for ocular herpes infection. Collectively, our results obtained using multiple infection models and virus strains establish BX795 as a promising lead compound for broad-spectrum antiviral applications in humans.
Asunto(s)
Ojo/virología , Herpes Simple/tratamiento farmacológico , Herpes Simple/virología , Herpesvirus Humano 1/efectos de los fármacos , Pirimidinas/uso terapéutico , Tiofenos/uso terapéutico , Animales , Antivirales/farmacología , Antivirales/uso terapéutico , Modelos Animales de Enfermedad , Activación Enzimática/efectos de los fármacos , Epitelio Corneal/patología , Epitelio Corneal/virología , Humanos , Ratones Endogámicos BALB C , Proteínas Proto-Oncogénicas c-akt/metabolismo , Pirimidinas/administración & dosificación , Pirimidinas/farmacología , Porcinos , Tiofenos/administración & dosificación , Tiofenos/farmacología , Virión/efectos de los fármacos , Virión/metabolismoRESUMEN
Herpes simplex virus type 1 (HSV-1) is an important factor for vision loss in developed countries. A challenging aspect of the ocular infection by HSV-1 is that common treatments, such as acyclovir, fail to provide effective topical remedies. Furthermore, it is not very clear whether the viral glycoproteins, required for HSV-1 entry into the host, can be targeted for an effective therapy against ocular herpes in vivo. Here, we demonstrate that HSV-1 envelope glycoprotein gD, which is essential for viral entry and spread, can be specifically targeted by topical applications of a small DNA aptamer to effectively control ocular infection by the virus. Our 45-nt-long DNA aptamer showed high affinity for HSV-1 gD (binding affinity constant [Kd] = 50 nM), which is strong enough to disrupt the binding of gD to its cognate host receptors. Our studies showed significant restriction of viral entry and replication in both in vitro and ex vivo studies. In vivo experiments in mice also resulted in loss of ocular infection under prophylactic treatment and statistically significant lower infection under therapeutic modality compared to random DNA controls. Thus, our studies validate the possibility that targeting HSV-1 entry glycoproteins, such as gD, can locally reduce the spread of infection and define a novel DNA aptamer-based approach to control HSV-1 infection of the eye.
RESUMEN
Heparan sulfate (HS) is ubiquitously expressed on mammalian cells. It is a polysaccharide that binds growth factors, cytokines, and chemokines, and thereby controls several important physiological functions. Ironically, many human pathogens including viruses interact with it for adherence to host cells. HS functions can be regulated by selective modifications and/or selective cleavage of the sugar chains from the cell surface. In mammals, heparanase (HPSE) is the only known enzyme capable of regulating HS functions via a selective endoglycosidase activity that cleaves polymeric HS chains at internal sites. During homeostasis, HPSE expression and its endoglycosidase activity are tightly regulated; however, under stress conditions, including infection, its expression may be upregulated, which could contribute directly to the onset of several disease pathologies. Here we focus on viral infections exemplified by herpes simplex virus, dengue virus, human papillomavirus, respiratory syncytial virus, adenovirus, hepatitis C virus, and porcine respiratory and reproductive syncytial virus to summarize recent advances in understanding the highly significant, but emerging roles, of the enzyme HPSE in viral infection, spread and pathogenesis.
RESUMEN
Herpes simplex virus-1 (HSV-1) causes life-long morbidities in humans. While fever blisters are more common, occasionally the cornea is infected resulting in vision loss. A very intriguing aspect of HSV-1 corneal infection is that the virus spread is normally restricted to only a small fraction of cells on the corneal surface that connect with each other in a dendritic fashion. Here, to develop a comprehensive understanding of the susceptibility of human corneal epithelial (HCE) cells to HSV-1 infection, we infected HCE cells at three different dosages of HSV-1 and measured the outcomes in terms of viral entry, gene and protein expression, viral replication and cytokine induction. In cultured cells, infectivity and cytokine induction were observed even at the minimum viral dosage tested, while a more pronounced dose-restricted infectivity was seen in ex vivo cultures of porcine corneas. Use of fluorescent HSV-1 virions demonstrated a pattern of viral spread ex vivo that mimics clinical findings. We conclude that HCE cell cultures are highly susceptible to infection whereas the cultured corneas demonstrate a higher ability to restrict the infection even in the absence of systemic immune system. The restriction is helped in part by local interferon response and the unique cellular architecture of the cornea.